Why do so many technology programmes in health and social care fail?

Similar documents
Analysing the role of complexity in explaining the fortunes of technology programmes: empirical application of the NASSS framework

HEALTH SYSTEMS FOR PROSPERITY AND SOLIDARITY

Human factors and design in future health care

Towards a Magna Carta for Data

Intellectual Property, Vaccine Production and Technology Transfer

Virtual Online Consultations: Advantages and Limitations (VOCAL). A mixed-method study at micro, meso and macro level

TECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19

ABHI Response to the Kennedy short study on Valuing Innovation

SESAR EXPLORATORY RESEARCH. Dr. Stella Tkatchova 21/07/2015

JTC1 Smart Ci,es workshop. Welcome!

Governing energy transitions towards a low-carbon society: the role of reflexive regulation and strategic experiments

Scoping Paper for. Horizon 2020 work programme Societal Challenge 4: Smart, Green and Integrated Transport

December Eucomed HTA Position Paper UK support from ABHI

Information & Communication Technology Strategy

The Potential Social and Economic Value of Innovation Procurement

Designing for recovery New challenges for large-scale, complex IT systems

The SONNETS Innovation Identification Framework

A review of the role and costs of clinical commissioning groups

15890/14 MVG/cb 1 DG G 3 C

SHTG primary submission process

6/14/2017. Engineering Future Cities The Value of Extreme Scenario Methodologies

Towards a systemic approach to unlock the transformative power of service innovation

THEME 4: FLEXIBILITY (TORRITI, READING)

Science, Technology, and Innovation for Sustainable Development: National Policy Frameworks in Asia and the Pacific Apiwat Ratanawaraha

Engaging UK Climate Service Providers a series of workshops in November 2014

Science education at crossroads: Socio-scientific issues and education

Catapult Network Summary

Initial draft of the technology framework. Contents. Informal document by the Chair

Executive Summary. The process. Intended use

Submission to the Productivity Commission inquiry into Intellectual Property Arrangements

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years

Our digital future. SEPA online. Facilitating effective engagement. Enabling business excellence. Sharing environmental information

Technology and Innovation in the NHS Scottish Health Innovations Ltd

THEFUTURERAILWAY THE INDUSTRY S RAIL TECHNICAL STRATEGY 2012 INNOVATION

GOVERNING BODY MEETING in Public 25 April 2018 Agenda Item 3.2

SMART PLACES WHAT. WHY. HOW.

Department of Energy s Legacy Management Program Development

EHR Optimization: Why Is Meaningful Use So Difficult?

The NHS England Assurance Framework: national report for consultation Chief Officer, Barnet Clinical Commissioning Group

OECD Innovation Strategy: Key Findings

SUCCESSFULLY IMPLEMENTING TRANSFORMATIONAL TECHNOLOGY IN HOSPITALS AND HEALTH SYSTEMS

ISO/IEC JTC1/WG11 (IT aspects of) Smart Cities

EU Research Integrity Initiative

Enabling ICT for. development

HealthTech: What does it mean for compliance?

Accountable Officer Report

Science Impact Enhancing the Use of USGS Science

International Financial Reporting Standards. IASC Foundation

"The future of Social Sciences and Humanities in Horizon 2020"

Draft Plan of Action Chair's Text Status 3 May 2008

Cisco Live Healthcare Innovation Roundtable Discussion. Brendan Lovelock: Cisco Brad Davies: Vector Consulting

The ICT industry as driver for competition, investment, growth and jobs if we make the right choices

Achieving the Systems Engineering Vision 2025

INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS. MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013

NERA Innovation Cluster Workshop Miranda Taylor, November 2016

EVCA Strategic Priorities

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

Prof. Geraint Ellis. School of Planning, rand Civil Engineering Queen s University,

Refining foresight approaches to crisis, inertia and transition

SWOT Analysis on thetheme ICT for Health

Deregulating Futures: The role of spectrum

Enhancing Government through the Transforming Application of Foresight

GIE response to public consultation Interoperability NC of ENTSOG

Smart Management for Smart Cities. How to induce strategy building and implementation

DIGITAL REACH: Digital skills for the hardest-to-reach young people. A new approach to engage the UK s most digitally disadvantaged

Competency Standard for Registration as a Professional Engineer

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation

Foresight and Scenario Development

Health Technology Assessment and the European Network for HTA

The Role of the Intellectual Property Office

Interoperable systems that are trusted and secure

Impact Case Study Template. Guidance Document

PRIMARY CARE CO-COMMISSIONING

Roadmap Pitch: Road2CPS - Roadmapping Project Platforms4CPS Roadmap Workshop

Creating Successful Public Private Partnerships Examining External Success Factors

G7 SCIENCE MINISTERS COMMUNIQUÉ

Open Systems Architecture in DoD Acquisition: Opportunities and Challenges

CCG 360 o stakeholder survey 2017/18

Counterfeit, Falsified and Substandard Medicines

Collaboration Agreement

Global Standards Symposium. Security, privacy and trust in standardisation. ICDPPC Chair John Edwards. 24 October 2016

1 Canada needs mining. 2 Canada s competitive advantage. 3 Challenges to the industry. 4 Collaboration and engagement

West Norfolk CCG. CCG 360 o stakeholder survey 2014 Main report. Version 1 Internal Use Only Version 7 Internal Use Only

Written response to the public consultation on the European Commission Green Paper: From

Research integrity. House of Commons Science and Technology Committee. Submission from the Royal Academy of Engineering.

Strategy for a Digital Preservation Program. Library and Archives Canada

Priorities for medical research in the UK

Project Status Update

THE IMPLICATIONS OF THE KNOWLEDGE-BASED ECONOMY FOR FUTURE SCIENCE AND TECHNOLOGY POLICIES

UB DRUSSA Experience and Lessons

NHS SOUTH NORFOLK CLINICAL COMMISSIONING GROUP COMMUNICATIONS AND ENGAGEMENT STRATEGY

clarification to bring legal certainty to these issues have been voiced in various position papers and statements.

Adopting Standards For a Changing Health Environment

Where does architecture end and technology begin? Rami Razouk The Aerospace Corporation

IBI GROUP S TOP 10. Smart City Strategy Success Factors

Transmission Innovation Strategy

ECU Research Commercialisation

Creating a Venture Capital Model for the Region a Best-practice Approach

SUSTAINABLE GROWTH AGREEMENT STIRLING COUNCIL AND SCOTTISH ENVIRONMENT PROTECTION AGENCY

Workshop 2: Benchmarking in OSH Future challenges to address with benchmark and exchanges of good practices

Transcription:

Why do so many technology programmes in health and social care fail? Professor Trisha Greenhalgh Acknowledging input from co-researchers and funding from Wellcome Trust and NIHR

The NASSS framework Health technology adoption, non-adoption, abandonment, and challenges to scale-up, spread and sustainability

Objective: To explain why telehealth (and similar) programmes fail Primary research: 6 diverse case studies of technology-supported health and social care programmes Secondary research: Narrative systematic review Followed for 2.5-3 years so far Draft framework covering 7 key domains Peer review and testing on 10 new case studies Final NASSS (nonadoption, abandonment, scale-up, spread, sustainability) framework

7. Continuous embedding and adaptation over time 5. Health / care organization(s) 6. Wider system Implementation work, implementation adaptation, tinkering work, adaptation, tinkering 4. Adopter system staff patient caregivers Health system 3. Value proposition 1. Condition 2. Technology The NASSS framework

SIMPLE Straightforward Predictable Few components COMPLICATED Multiple interacting components or issues COMPLEX Dynamic, unpredictable, not easily disaggregated into constituent components

COMPLEXITY can occur in various domains Clinical Technical Value-related People-related Organisational / inter-organisational Environmental EACH OF THESE DOMAINS MAY HAVE ELEMENTS OF Structural or logistical complexity (scale/ scope/ pace/ resources etc) Socio-political complexity (stakeholder goals /conflicts of interest etc) Emergent complexity (change over time / scope creep etc)

1. CONDITION 1A Nature of condition or illness 1B Comorbidities 1C Socio-cultural factors

DOMAIN 1: The condition or illness THE CONDITION CO-MORBIDITIES / SOCIO-CULTURAL FACTORS SIMPLE OR COMPLICATED Well-characterized, wellunderstood, predictable (=> standardised management) Unlikely to affect care significantly COMPLEX Poorly characterised, unpredictable or high-risk Pose significant challenges to care planning & services

1. CONDITION 1A Nature of condition or illness 1B Comorbidities 1C Socio-cultural factors TECHNOLOGY 2B Knowledge to use 2D Supply model 2A Material properties 2C Knowledge generated 2E Who owns the IP?

DOMAIN 2: The technology WHAT ARE THE TECHNOLOGY S MATERIAL FEATURES? SIMPLE OR COMPLICATED Already installed or off-the-shelf; dependable; freestanding OR interoperable with current system COMPLEX Not yet developed; inter-operability [will be] a headache WHAT KNOWLEDGE IS NEEDED TO USE IT? WHAT KIND OF KNOWLEDGE DOES IT BRING INTO PLAY? None or a simple set of instructions / IT support Data generated directly measures [changes in] the condition Advanced training plus ongoing support Questionable link between data and [change in] condition

DOMAIN 2: The technology WHAT IS THE TECHNOLOGY SUPPLY MODEL? WHO OWNS THE IP GENERATED BY THE TECHNOLOGY? SIMPLE OR COMPLICATED Generic, plug-and-play or COTS (customisable off-theshelf); easily substituted Data remains on local system; its ownership is unambiguous and agreed COMPLEX Requires significant reconfiguration of current system; hard to substitute Technology generates higher-order data e.g. algorithms, whose IP is contested

3. VALUE PROPOSITION 3A Supply-side value (to developer) 3B Demand-side value (to patient) 1. CONDITION 1A Nature of condition or illness 1B Comorbidities 1C Socio-cultural factors TECHNOLOGY 2B Knowledge to use 2D Supply model 2A Material properties 2C Knowledge generated 2E Who owns the IP?

DOMAIN 3: The value proposition WHAT IS THE DEVELOPER S BUSINESS CASE? [SUPPLY-SIDE VALUE] WHAT IS THE TECHNOLOGY S DESIRABILITY, EFFICACY, SAFETY AND COST-EFFECTIVENESS? [DEMAND-SIDE VALUE] SIMPLE OR COMPLICATED Business case is clear and rests on firm assumptions; strong chance of return on investment Technology is known to be desirable for patients, safe and cost-effective COMPLEX Business case rests on questionable assumptions; significant risk to investors Patients may not want or need the technology, or it may be unsafe or unaffordable

4. ADOPTERS 4A Staff (role, identity) 4B Patient (passive v active input) 4C Carers (available, type of input) 3. VALUE PROPOSITION 3A Supply-side value (to developer) 3B Demand-side value (to patient) 1. CONDITION 1A Nature of condition or illness 1B Comorbidities 1C Socio-cultural factors 2. TECHNOLOGY 2A 2B Knowledge Material properties to use 2C 2D Supply Knowledge model to use 2A Material properties 2C 2B Knowledge generated 2E 2D Who Supply owns model the IP?

DOMAIN 4: The adopter system WHAT CHANGES ARE IMPLIED FOR STAFF? SIMPLE OR COMPLICATED No changes OR staff must learn new roles OR new staff be appointed COMPLEX Threat to people s jobs, scope of practice or professional identity WHAT IS EXPECTED OF THE PATIENT OR PRIMARY CARER? WHAT IS ASSUMED ABOUT THE WIDER CARE NETWORK? Nothing OR very routine tasks e.g. log on, converse, enter data No lay carer assumed Complex tasks e.g. make judgements, adjust treatment Network of lay carers is assumed

5. ORGANISATION 5A Capacity to innovate 5B Readiness for this technology 5C Nature of adoption / funding decision 5D Extent of change needed to organisational routines 5E Work needed to implement change 4. ADOPTERS 4A Staff (role, identity) 4B Patient (passive v active input) 4C Carers (available, type of input) 3. VALUE PROPOSITION 3A Supply-side value (to developer) 3B Demand-side value (to patient) 1. CONDITION 1A Nature of condition or illness 1B Comorbidities 1C Socio-cultural factors TECHNOLOGY 2B Knowledge to use 2D Supply model 2A Material properties 2C Knowledge generated 2E Who owns the IP?

DOMAIN 5: The organisation WHAT IS ITS CAPACITY TO INNOVATE (IN ANYTHING)? SIMPLE OR COMPLICATED Well-led; flat hierarchies; good relationships; slack resources; risk-taking is encouraged COMPLEX Weak leadership; poor relations; rigid hierarchies; severe resource problems; risk-taking is punished HOW READY IS IT FOR THIS TECHNOLOGY- SUPPORTED CHANGE? High tension for change; good innovation-system fit; widespread support (or opponents lack power) No tension for change; poor innovation-system fit; key opponents have wrecking power

DOMAIN 5: The organisation HOW EASY WILL THE FUNDING DECISION BE? IMPLICATIONS FOR TEAM ROUTINES WHAT WORK IS NEEDED TO IMPLEMENT? SIMPLE OR COMPLICATED One organisation OR existing partnership; adequate funds; anticipated cost-neutral or savings; no new infrastructure None or minor Shared vision already exists; few measures needed to develop and evaluate new practices COMPLEX Many organisations, not yet in partnership; funding model depends on cross-system savings Significant disruptive changes needed Significant work needed to build shared vision and implement it

6. WIDER SYSTEM e.g. 6A Political / policy context 6B Regulatory / legal issues 6C Professional bodies 6D Socio-cultural context 5. ORGANISATION 5A Capacity to innovate 5B Readiness for this technology 5C Nature of adoption / funding decision 5D Extent of change needed to organisational routines 5E Work needed to implement change 4. ADOPTERS 4A Staff (role, identity) 4B Patient (passive v active input) 4C Carers (available, type of input) 3. VALUE PROPOSITION 3A Supply-side value (to developer) 3B Demand-side value (to patient) 1. CONDITION 1A Nature of condition or illness 1B Comorbidities 1C Socio-cultural factors TECHNOLOGY 2B Knowledge to use 2D Supply model 2A Material properties 2C Knowledge generated 2E Who owns the IP?

DOMAIN 6: The wider system POLITICAL AND POLICY CONTEXT SIMPLE OR COMPLICATED Current or potential policy push COMPLEX Political opposition REGULATORY OR LEGAL HURDLES PROFESSIONAL BODIES CITIZENS / LAY PUBLIC None or easily surmountable Positive or open to discussion Positive or open to discussion Many, no easy way through Opposed Opposed

7. EMBEDDING AND ADAPTATION OVER TIME 7A Scope for adaptation over time 7B Organisational resilience 6. WIDER SYSTEM e.g. 6A Political / policy context 6B Regulatory / legal issues 6C Professional bodies 6D Socio-cultural context 5. ORGANISATION 5A Capacity to innovate 5B Readiness for this technology 5C Nature of adoption / funding decision 5D Extent of change needed to organisational routines 5E Work needed to implement change 4. ADOPTERS 4A Staff (role, identity) 4B Patient (passive v active input) 4C Carers (available, type of input) 3. VALUE PROPOSITION 3A Supply-side value (to developer) 3B Demand-side value (to patient) 1. CONDITION 1A Nature of condition or illness 1B Comorbidities 1C Socio-cultural factors TECHNOLOGY 2B Knowledge to use 2D Supply model 2A Material properties 2C Knowledge generated 2E Who owns the IP?

DOMAIN 7: Embedding and adapting over time HOW MUCH SCOPE IS THERE TO ADAPT / CO- EVOLVE TECHNOLOGIES AND SERVICES? HOW RESILIENT IS THE ORGANISATION FOR ADAPTING TO CRITICAL EVENTS? SIMPLE OR COMPLICATED Considerable scope, built into programme design Sense-making, reflection and adaptive action are ongoing and encouraged COMPLEX Significant barriers to further adaptation Implementation model is rigid and inflexible; no reflection / adaptation allowed

7. EMBEDDING AND ADAPTATION OVER TIME 7A Scope for adaptation over time 7B Organisational resilience 6. WIDER SYSTEM e.g. 6A Political / policy context 6B Regulatory / legal issues 6C Professional bodies 6D Socio-cultural context 5. ORGANISATION 5A Capacity to innovate 5B Readiness for this technology 5C Nature of adoption / funding decision 5D Extent of change needed to organisational routines 5E Work needed to implement change 4. ADOPTERS 4A Staff (role, identity) 4B Patient (passive v active input) 4C Carers (available, type of input) 3. VALUE PROPOSITION 3A Supply-side value (to developer) 3B Demand-side value (to patient) 1. CONDITION 1A Nature of condition or illness 1B Comorbidities 1C Socio-cultural factors 2. TECHNOLOGY 2A Material properties 2B Knowledge to use 2C Knowledge generated 2D Supply model 2E Who owns the IP?

THE NASSS HYPOTHESIS A technology-supported programme will be readily adopted, spread and sustained if all domains are simple If several domains are complicated, the programme will be difficult, expensive and slow (but not impossible) to implement and sustain If several domains are complex, it will be almost impossible to achieve sustained and widespread adoption of the programme

WHAT TO DO WITH THE NASSS FRAMEWORK? 1. Inform technology design 2. Reject technology solutions that have limited chance of success 3. Explain past failures 4. Use NASSS Complexity Assessment Tool to identify, understand, reduce and manage complexity in new and emerging programs 5. YOUR IDEA HERE We have begun to work with policymakers, design consultancies and technology companies in UK, Australia, Italy & Canada to apply the NASSS framework

IN PROGRESS: USING NASSS TO MANAGE COMPLEXITY IDENTIFY AND UNDERSTAND COMPLEXITY Apply NASSS complexity assessment tool Tease out uncertainties and interdependencies (e.g. via narrative) REDUCE COMPLEXITY WHERE POSSIBBLE Limit scale / scope / interdependencies / pace (extend timescale) RUN WITH COMPLEXITY e.g. Strengthen programme leadership Co-develop and sustain a clear and compelling vision Develop individuals and support their adaptive actions Provide slack resources Create incentives (but leave the detail to front-line people) Build relationships and manage stakeholder conflict Control programme growth (e.g. minimise scope creep) Improve policy or regulatory context

THANK YOU FOR YOUR ATTENTION Professor Trisha Greenhalgh @trishgreenhalgh